Research
We believe in sharing the research findings of our teams and partners openly to accelerate understanding of human health and disease. We strongly encourage researchers to deposit manuscripts as preprints before peer review to increase access to research findings and to communicate results more quickly. Since 2015, we have supported more than 8,000 publications.
-
Neoadjuvant androgen deprivation therapy with or without Fc-enhanced non-fucosylated anti-CTLA-4 (BMS-986218) in high risk localized prostate cancer: a randomized phase 1 trial
Ager CR, Obradovic A, McCann P, et al. (2024) | medRxiv
-
Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors
Jamison JK, Zhou M, Gelmann EP, Luk L, et al. (2024) | The Oncologist
-
Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus
Law, C., Wacleche, V.S., Cao, Y. et al. (2024) | Nature
-
Single-cell analysis of human diversity in circulating immune cells
Kian Hong Kock, Le Min Tan, Kyung Yeon Han et al. (2024) | bioRxiv
-
Active biointegrated living electronics for managing inflammation
Jiuyun Shi, Saehyun Kim, Pengju Li et al. (2024) | Science
-
Network-based elucidation of colon cancer drug resistance mechanisms by phosphoproteomic time-series analysis
Rosenberger G, Li W, Turunen M, et al. (2024) | Nature Communications
-
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Wasko, U.N., Jiang, J., Dalton, T.C. et al. (2024) | Nature
-
Multimodal profiling reveals tissue-directed signatures of human immune cells altered with age
Steven Wells, Daniel Rainbow, Michael Mark et al. (2024) | bioRxiv